146 related articles for article (PubMed ID: 16547074)
41. Unraveling the Structure-Dependent Inhibitory Effects of Ginsenoside Series Compounds on Human Cytochrome P450 1B1.
Zhao T; Chen X; Yu H; Du J; Wang D; Wang C; Meng Q; Sun H; Liu K; Wu J
Curr Drug Metab; 2022; 23(7):553-561. PubMed ID: 35652395
[TBL] [Abstract][Full Text] [Related]
42. The inhibitory effect of 20(S)-protopanaxatriol (ppt) towards UGT1A1 and UGT2B7.
He YJ; Fang ZZ; Ge GB; Jiang P; Jin HZ; Zhang WD; Yang L
Phytother Res; 2013 Apr; 27(4):628-32. PubMed ID: 22736593
[TBL] [Abstract][Full Text] [Related]
43. Ginsenoside metabolites inhibit P-glycoprotein in vitro and in situ using three absorption models.
Li N; Wang D; Ge G; Wang X; Liu Y; Yang L
Planta Med; 2014 Mar; 80(4):290-6. PubMed ID: 24493631
[TBL] [Abstract][Full Text] [Related]
44. Anti-stress effects of 20(S)-protopanaxadiol and 20(S)-protopanaxatriol in immobilized mice.
Oh HA; Kim DE; Choi HJ; Kim NJ; Kim DH
Biol Pharm Bull; 2015; 38(2):331-5. PubMed ID: 25747994
[TBL] [Abstract][Full Text] [Related]
45. Structure-activity relationship and substrate-dependent phenomena in effects of ginsenosides on activities of drug-metabolizing P450 enzymes.
Hao M; Zhao Y; Chen P; Huang H; Liu H; Jiang H; Zhang R; Wang H
PLoS One; 2008 Jul; 3(7):e2697. PubMed ID: 18628990
[TBL] [Abstract][Full Text] [Related]
46. Production of a bioactive unnatural ginsenoside by metabolically engineered yeasts based on a new UDP-glycosyltransferase from Bacillus subtilis.
Liang H; Hu Z; Zhang T; Gong T; Chen J; Zhu P; Li Y; Yang J
Metab Eng; 2017 Nov; 44():60-69. PubMed ID: 28778764
[TBL] [Abstract][Full Text] [Related]
47. Tissue distribution and cytochrome P450 inhibition of sesaminol and its tetrahydrofuranoid metabolites.
Jan KC; Chang YW; Hwang LS; Ho CT
J Agric Food Chem; 2012 Sep; 60(35):8616-23. PubMed ID: 22894606
[TBL] [Abstract][Full Text] [Related]
48. Cytochromes P450 Inhibitory Excipient-Based Self-Microemulsions for the Improved Bioavailability of Protopanaxatriol and Protopanaxadiol: Preparation and Evaluation.
Yang F; Zhou J; Liu C; Hu X; Pan R; Chang Q; Liu X; Liao Y
Planta Med; 2017 Mar; 83(5):453-460. PubMed ID: 27220080
[TBL] [Abstract][Full Text] [Related]
49. Optimization of a cytochrome P450 oxidation system for enhancing protopanaxadiol production in Saccharomyces cerevisiae.
Zhao F; Bai P; Liu T; Li D; Zhang X; Lu W; Yuan Y
Biotechnol Bioeng; 2016 Aug; 113(8):1787-95. PubMed ID: 26757342
[TBL] [Abstract][Full Text] [Related]
50. Multiple circulating alkaloids and saponins from intravenous Kang-Ai injection inhibit human cytochrome P450 and UDP-glucuronosyltransferase isozymes: potential drug-drug interactions.
Qin Z; Jia M; Yang J; Xing H; Yin Z; Yao Z; Zhang X; Yao X
Chin Med; 2020; 15():69. PubMed ID: 32655683
[TBL] [Abstract][Full Text] [Related]
51. The ginsenoside PPD exerts anti-endometriosis effects by suppressing estrogen receptor-mediated inhibition of endometrial stromal cell autophagy and NK cell cytotoxicity.
Zhang B; Zhou WJ; Gu CJ; Wu K; Yang HL; Mei J; Yu JJ; Hou XF; Sun JS; Xu FY; Li DJ; Jin LP; Li MQ
Cell Death Dis; 2018 May; 9(5):574. PubMed ID: 29760378
[TBL] [Abstract][Full Text] [Related]
52. Pharmacokinetic Drug Interactions with Panax ginseng.
Ramanathan MR; Penzak SR
Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):545-557. PubMed ID: 27864798
[TBL] [Abstract][Full Text] [Related]
53. Anti-fatigue Effects of 20(S)-Protopanaxadiol and 20(S)-Protopanaxatriol in Mice.
Oh HA; Kim DE; Choi HJ; Kim NJ; Kim DH
Biol Pharm Bull; 2015; 38(9):1415-9. PubMed ID: 26328499
[TBL] [Abstract][Full Text] [Related]
54. Improvement of memory in mice and increase of hippocampal excitability in rats by ginsenoside Rg1's metabolites ginsenoside Rh1 and protopanaxatriol.
Wang YZ; Chen J; Chu SF; Wang YS; Wang XY; Chen NH; Zhang JT
J Pharmacol Sci; 2009 Apr; 109(4):504-10. PubMed ID: 19372633
[TBL] [Abstract][Full Text] [Related]
55. Ginsenoside 20(S)-Protopanaxadiol Suppresses Viability of Human Glioblastoma Cells via Down-regulation of Cell Adhesion Proteins and Cell-cycle Arrest.
Wanderi C; Kim E; Chang S; Choi C; Choi K
Anticancer Res; 2016 Mar; 36(3):925-32. PubMed ID: 26976980
[TBL] [Abstract][Full Text] [Related]
56. Identification of 20(R, S)-protopanaxadiol and 20(R, S)-protopanaxatriol for potential selective modulation of glucocorticoid receptor.
Zhang T; Liang Y; Zuo P; Yan M; Jing S; Li T; Wang Y; Zhang J; Wei Z
Food Chem Toxicol; 2019 Sep; 131():110642. PubMed ID: 31247261
[TBL] [Abstract][Full Text] [Related]
57. Insights into gastrointestinal microbiota-generated ginsenoside metabolites and their bioactivities.
Yang L; Zou H; Gao Y; Luo J; Xie X; Meng W; Zhou H; Tan Z
Drug Metab Rev; 2020 Feb; 52(1):125-138. PubMed ID: 31984805
[TBL] [Abstract][Full Text] [Related]
58. [Effect of ginsenoside total saponinon on regulation of P450 of livers of rats after γ-ray irradiation].
Yi JF; Wu B; Liu CL; Gao Y
Zhongguo Zhong Yao Za Zhi; 2015 Oct; 40(20):4037-43. PubMed ID: 27062824
[TBL] [Abstract][Full Text] [Related]
59. Use of a Promiscuous Glycosyltransferase from Bacillus subtilis 168 for the Enzymatic Synthesis of Novel Protopanaxatriol-Type Ginsenosides.
Dai L; Li J; Yang J; Zhu Y; Men Y; Zeng Y; Cai Y; Dong C; Dai Z; Zhang X; Sun Y
J Agric Food Chem; 2018 Jan; 66(4):943-949. PubMed ID: 29338263
[TBL] [Abstract][Full Text] [Related]
60. Producing aglycons of ginsenosides in bakers' yeast.
Dai Z; Wang B; Liu Y; Shi M; Wang D; Zhang X; Liu T; Huang L; Zhang X
Sci Rep; 2014 Jan; 4():3698. PubMed ID: 24424342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
